Eisler Capital (UK)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Eisler Capital (UK)'s BMY Position: Q3 2024 in Review
Eisler Capital (UK) reduced its Bristol-Myers Squibb (BMY) stake by 68% in Q3 2024, selling an estimated $1.11M and leaving 11,317 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #522.
Eisler Capital (UK) first reported a position in BMY in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.45M in Q2 2024. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.
- Eisler Capital (UK) held 11,317 shares of Bristol-Myers Squibb worth $586K as of Q3 2024.
- Eisler Capital (UK) sold 23,602 Bristol-Myers Squibb shares in Q3 2024, an estimated $1.11M.
- Bristol-Myers Squibb made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #522 holding.
- Eisler Capital (UK) first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 4 quarters since.
- Eisler Capital (UK)'s Bristol-Myers Squibb position peaked at $1.45M in Q2 2024.
- 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.
Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.